nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—polycystic ovary syndrome—type 2 diabetes mellitus	0.293	0.547	CtDrD
Metformin—metabolic syndrome X—type 2 diabetes mellitus	0.243	0.453	CtDrD
Metformin—ND1—type 2 diabetes mellitus	0.201	1	CbGaD
Metformin—NDUFA3—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000497	0.284	CbGdCrCtD
Metformin—NDUFB1—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000497	0.284	CbGdCrCtD
Metformin—NDUFA7—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000376	0.216	CbGdCrCtD
Metformin—NDUFC1—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000376	0.216	CbGdCrCtD
Metformin—NDUFA2—pancreas—type 2 diabetes mellitus	0.000221	0.00335	CbGeAlD
Metformin—NDUFB7—nephron tubule—type 2 diabetes mellitus	0.000219	0.00333	CbGeAlD
Metformin—NDUFB1—nephron tubule—type 2 diabetes mellitus	0.000218	0.00331	CbGeAlD
Metformin—NDUFS8—nephron tubule—type 2 diabetes mellitus	0.000218	0.00331	CbGeAlD
Metformin—PRKAB1—islet of Langerhans—type 2 diabetes mellitus	0.000218	0.0033	CbGeAlD
Metformin—NDUFB8—retina—type 2 diabetes mellitus	0.000217	0.0033	CbGeAlD
Metformin—NDUFA10—cardiovascular system—type 2 diabetes mellitus	0.000216	0.00329	CbGeAlD
Metformin—NDUFA2—cortex of kidney—type 2 diabetes mellitus	0.000216	0.00329	CbGeAlD
Metformin—NDUFB5—nephron tubule—type 2 diabetes mellitus	0.000215	0.00326	CbGeAlD
Metformin—NDUFA6—nephron tubule—type 2 diabetes mellitus	0.000215	0.00326	CbGeAlD
Metformin—NDUFC1—cardiovascular system—type 2 diabetes mellitus	0.000215	0.00326	CbGeAlD
Metformin—NDUFV3—liver—type 2 diabetes mellitus	0.000214	0.00324	CbGeAlD
Metformin—NDUFS4—nephron tubule—type 2 diabetes mellitus	0.000213	0.00324	CbGeAlD
Metformin—NDUFB2—cardiovascular system—type 2 diabetes mellitus	0.000213	0.00323	CbGeAlD
Metformin—NDUFA10—kidney—type 2 diabetes mellitus	0.000212	0.00322	CbGeAlD
Metformin—NDUFB4—nephron tubule—type 2 diabetes mellitus	0.000211	0.0032	CbGeAlD
Metformin—NDUFA10—pancreas—type 2 diabetes mellitus	0.00021	0.0032	CbGeAlD
Metformin—NDUFAB1—nephron tubule—type 2 diabetes mellitus	0.000209	0.00318	CbGeAlD
Metformin—ND6—cardiovascular system—type 2 diabetes mellitus	0.000209	0.00318	CbGeAlD
Metformin—NDUFC1—pancreas—type 2 diabetes mellitus	0.000209	0.00317	CbGeAlD
Metformin—NDUFB2—kidney—type 2 diabetes mellitus	0.000208	0.00316	CbGeAlD
Metformin—NDUFA8—nephron tubule—type 2 diabetes mellitus	0.000208	0.00316	CbGeAlD
Metformin—NDUFS6—liver—type 2 diabetes mellitus	0.000208	0.00316	CbGeAlD
Metformin—NDUFB3—cardiovascular system—type 2 diabetes mellitus	0.000208	0.00315	CbGeAlD
Metformin—NDUFA4—nephron tubule—type 2 diabetes mellitus	0.000207	0.00314	CbGeAlD
Metformin—NDUFB2—pancreas—type 2 diabetes mellitus	0.000207	0.00314	CbGeAlD
Metformin—NDUFA10—cortex of kidney—type 2 diabetes mellitus	0.000206	0.00313	CbGeAlD
Metformin—NDUFV1—nephron tubule—type 2 diabetes mellitus	0.000206	0.00312	CbGeAlD
Metformin—NDUFB11—nephron tubule—type 2 diabetes mellitus	0.000206	0.00312	CbGeAlD
Metformin—NDUFAF1—pancreas—type 2 diabetes mellitus	0.000205	0.00312	CbGeAlD
Metformin—ND6—kidney—type 2 diabetes mellitus	0.000205	0.00311	CbGeAlD
Metformin—NDUFC1—cortex of kidney—type 2 diabetes mellitus	0.000204	0.00311	CbGeAlD
Metformin—NDUFS5—nephron tubule—type 2 diabetes mellitus	0.000204	0.0031	CbGeAlD
Metformin—NDUFB8—nephron tubule—type 2 diabetes mellitus	0.000204	0.0031	CbGeAlD
Metformin—ND6—pancreas—type 2 diabetes mellitus	0.000203	0.00309	CbGeAlD
Metformin—NDUFA5—cardiovascular system—type 2 diabetes mellitus	0.000203	0.00308	CbGeAlD
Metformin—NDUFA11—cardiovascular system—type 2 diabetes mellitus	0.000203	0.00308	CbGeAlD
Metformin—NDUFB2—cortex of kidney—type 2 diabetes mellitus	0.000203	0.00308	CbGeAlD
Metformin—NDUFA7—liver—type 2 diabetes mellitus	0.000202	0.00308	CbGeAlD
Metformin—NDUFAF2—pancreas—type 2 diabetes mellitus	0.000202	0.00306	CbGeAlD
Metformin—NDUFB3—pancreas—type 2 diabetes mellitus	0.000202	0.00306	CbGeAlD
Metformin—NDUFB6—cardiovascular system—type 2 diabetes mellitus	0.000201	0.00306	CbGeAlD
Metformin—NDUFAF4—cardiovascular system—type 2 diabetes mellitus	0.000201	0.00306	CbGeAlD
Metformin—NDUFAF1—cortex of kidney—type 2 diabetes mellitus	0.000201	0.00305	CbGeAlD
Metformin—NDUFA2—adipose tissue—type 2 diabetes mellitus	0.0002	0.00304	CbGeAlD
Metformin—NDUFS1—cardiovascular system—type 2 diabetes mellitus	0.0002	0.00304	CbGeAlD
Metformin—NDUFA11—kidney—type 2 diabetes mellitus	0.000198	0.00301	CbGeAlD
Metformin—NDUFA5—kidney—type 2 diabetes mellitus	0.000198	0.00301	CbGeAlD
Metformin—NDUFB10—cardiovascular system—type 2 diabetes mellitus	0.000198	0.00301	CbGeAlD
Metformin—NDUFB3—cortex of kidney—type 2 diabetes mellitus	0.000198	0.003	CbGeAlD
Metformin—NDUFAF2—cortex of kidney—type 2 diabetes mellitus	0.000198	0.003	CbGeAlD
Metformin—NDUFA5—pancreas—type 2 diabetes mellitus	0.000197	0.00299	CbGeAlD
Metformin—NDUFA11—pancreas—type 2 diabetes mellitus	0.000197	0.00299	CbGeAlD
Metformin—NDUFS2—islet of Langerhans—type 2 diabetes mellitus	0.000197	0.00299	CbGeAlD
Metformin—NDUFA12—cardiovascular system—type 2 diabetes mellitus	0.000197	0.00299	CbGeAlD
Metformin—NDUFB7—cardiovascular system—type 2 diabetes mellitus	0.000197	0.00299	CbGeAlD
Metformin—NDUFB6—pancreas—type 2 diabetes mellitus	0.000196	0.00297	CbGeAlD
Metformin—NDUFAF4—pancreas—type 2 diabetes mellitus	0.000196	0.00297	CbGeAlD
Metformin—NDUFS8—cardiovascular system—type 2 diabetes mellitus	0.000196	0.00297	CbGeAlD
Metformin—NDUFB1—cardiovascular system—type 2 diabetes mellitus	0.000196	0.00297	CbGeAlD
Metformin—NDUFS1—kidney—type 2 diabetes mellitus	0.000195	0.00297	CbGeAlD
Metformin—NDUFS3—islet of Langerhans—type 2 diabetes mellitus	0.000195	0.00296	CbGeAlD
Metformin—NDUFS1—pancreas—type 2 diabetes mellitus	0.000194	0.00295	CbGeAlD
Metformin—NDUFB10—kidney—type 2 diabetes mellitus	0.000194	0.00295	CbGeAlD
Metformin—NDUFA5—cortex of kidney—type 2 diabetes mellitus	0.000193	0.00294	CbGeAlD
Metformin—NDUFA11—cortex of kidney—type 2 diabetes mellitus	0.000193	0.00294	CbGeAlD
Metformin—SLC29A4—liver—type 2 diabetes mellitus	0.000193	0.00293	CbGeAlD
Metformin—NDUFB5—cardiovascular system—type 2 diabetes mellitus	0.000193	0.00293	CbGeAlD
Metformin—NDUFA6—cardiovascular system—type 2 diabetes mellitus	0.000193	0.00293	CbGeAlD
Metformin—NDUFB10—pancreas—type 2 diabetes mellitus	0.000193	0.00293	CbGeAlD
Metformin—NDUFB7—kidney—type 2 diabetes mellitus	0.000193	0.00293	CbGeAlD
Metformin—NDUFA12—kidney—type 2 diabetes mellitus	0.000193	0.00293	CbGeAlD
Metformin—NDUFAF4—cortex of kidney—type 2 diabetes mellitus	0.000192	0.00291	CbGeAlD
Metformin—NDUFB6—cortex of kidney—type 2 diabetes mellitus	0.000192	0.00291	CbGeAlD
Metformin—NDUFS4—cardiovascular system—type 2 diabetes mellitus	0.000192	0.00291	CbGeAlD
Metformin—NDUFS7—nephron tubule—type 2 diabetes mellitus	0.000191	0.00291	CbGeAlD
Metformin—NDUFB7—pancreas—type 2 diabetes mellitus	0.000191	0.00291	CbGeAlD
Metformin—NDUFA12—pancreas—type 2 diabetes mellitus	0.000191	0.00291	CbGeAlD
Metformin—NDUFB1—kidney—type 2 diabetes mellitus	0.000191	0.00291	CbGeAlD
Metformin—NDUFS8—kidney—type 2 diabetes mellitus	0.000191	0.00291	CbGeAlD
Metformin—NDUFA10—adipose tissue—type 2 diabetes mellitus	0.000191	0.0029	CbGeAlD
Metformin—NDUFS1—cortex of kidney—type 2 diabetes mellitus	0.00019	0.00289	CbGeAlD
Metformin—NDUFS8—pancreas—type 2 diabetes mellitus	0.00019	0.00289	CbGeAlD
Metformin—NDUFB1—pancreas—type 2 diabetes mellitus	0.00019	0.00289	CbGeAlD
Metformin—NDUFC1—adipose tissue—type 2 diabetes mellitus	0.000189	0.00288	CbGeAlD
Metformin—NDUFB4—cardiovascular system—type 2 diabetes mellitus	0.000189	0.00287	CbGeAlD
Metformin—NDUFAF3—liver—type 2 diabetes mellitus	0.000189	0.00287	CbGeAlD
Metformin—NDUFB10—cortex of kidney—type 2 diabetes mellitus	0.000189	0.00287	CbGeAlD
Metformin—NDUFB5—kidney—type 2 diabetes mellitus	0.000189	0.00287	CbGeAlD
Metformin—NDUFA6—kidney—type 2 diabetes mellitus	0.000189	0.00287	CbGeAlD
Metformin—NDUFAB1—cardiovascular system—type 2 diabetes mellitus	0.000188	0.00286	CbGeAlD
Metformin—NDUFB7—cortex of kidney—type 2 diabetes mellitus	0.000188	0.00285	CbGeAlD
Metformin—NDUFA12—cortex of kidney—type 2 diabetes mellitus	0.000188	0.00285	CbGeAlD
Metformin—NDUFB2—adipose tissue—type 2 diabetes mellitus	0.000188	0.00285	CbGeAlD
Metformin—NDUFB5—pancreas—type 2 diabetes mellitus	0.000188	0.00285	CbGeAlD
Metformin—NDUFA6—pancreas—type 2 diabetes mellitus	0.000188	0.00285	CbGeAlD
Metformin—NDUFB9—cardiovascular system—type 2 diabetes mellitus	0.000187	0.00284	CbGeAlD
Metformin—NDUFA8—cardiovascular system—type 2 diabetes mellitus	0.000187	0.00284	CbGeAlD
Metformin—NDUFB1—cortex of kidney—type 2 diabetes mellitus	0.000186	0.00283	CbGeAlD
Metformin—NDUFS8—cortex of kidney—type 2 diabetes mellitus	0.000186	0.00283	CbGeAlD
Metformin—NDUFAF1—adipose tissue—type 2 diabetes mellitus	0.000186	0.00283	CbGeAlD
Metformin—PRKAB1—retina—type 2 diabetes mellitus	0.000186	0.00283	CbGeAlD
Metformin—NDUFA4—cardiovascular system—type 2 diabetes mellitus	0.000186	0.00282	CbGeAlD
Metformin—NDUFB4—kidney—type 2 diabetes mellitus	0.000185	0.00281	CbGeAlD
Metformin—NDUFB11—cardiovascular system—type 2 diabetes mellitus	0.000185	0.0028	CbGeAlD
Metformin—NDUFV1—cardiovascular system—type 2 diabetes mellitus	0.000185	0.0028	CbGeAlD
Metformin—NDUFAB1—kidney—type 2 diabetes mellitus	0.000184	0.0028	CbGeAlD
Metformin—NDUFB4—pancreas—type 2 diabetes mellitus	0.000184	0.00279	CbGeAlD
Metformin—NDUFA6—cortex of kidney—type 2 diabetes mellitus	0.000184	0.00279	CbGeAlD
Metformin—NDUFB5—cortex of kidney—type 2 diabetes mellitus	0.000184	0.00279	CbGeAlD
Metformin—NDUFS5—cardiovascular system—type 2 diabetes mellitus	0.000184	0.00279	CbGeAlD
Metformin—NDUFB8—cardiovascular system—type 2 diabetes mellitus	0.000184	0.00279	CbGeAlD
Metformin—NDUFAF2—adipose tissue—type 2 diabetes mellitus	0.000183	0.00278	CbGeAlD
Metformin—NDUFB3—adipose tissue—type 2 diabetes mellitus	0.000183	0.00278	CbGeAlD
Metformin—NDUFB9—kidney—type 2 diabetes mellitus	0.000183	0.00278	CbGeAlD
Metformin—NDUFA8—kidney—type 2 diabetes mellitus	0.000183	0.00278	CbGeAlD
Metformin—NDUFAB1—pancreas—type 2 diabetes mellitus	0.000183	0.00278	CbGeAlD
Metformin—NDUFS4—cortex of kidney—type 2 diabetes mellitus	0.000183	0.00278	CbGeAlD
Metformin—NDUFA4—kidney—type 2 diabetes mellitus	0.000182	0.00276	CbGeAlD
Metformin—NDUFA8—pancreas—type 2 diabetes mellitus	0.000182	0.00276	CbGeAlD
Metformin—NDUFB9—pancreas—type 2 diabetes mellitus	0.000182	0.00276	CbGeAlD
Metformin—NDUFV1—kidney—type 2 diabetes mellitus	0.000181	0.00274	CbGeAlD
Metformin—NDUFB11—kidney—type 2 diabetes mellitus	0.000181	0.00274	CbGeAlD
Metformin—NDUFA4—pancreas—type 2 diabetes mellitus	0.000181	0.00274	CbGeAlD
Metformin—NDUFB4—cortex of kidney—type 2 diabetes mellitus	0.00018	0.00274	CbGeAlD
Metformin—NDUFB8—kidney—type 2 diabetes mellitus	0.00018	0.00273	CbGeAlD
Metformin—NDUFS5—kidney—type 2 diabetes mellitus	0.00018	0.00273	CbGeAlD
Metformin—NDUFV1—pancreas—type 2 diabetes mellitus	0.000179	0.00273	CbGeAlD
Metformin—NDUFB11—pancreas—type 2 diabetes mellitus	0.000179	0.00273	CbGeAlD
Metformin—NDUFAB1—cortex of kidney—type 2 diabetes mellitus	0.000179	0.00272	CbGeAlD
Metformin—NDUFA5—adipose tissue—type 2 diabetes mellitus	0.000179	0.00272	CbGeAlD
Metformin—NDUFA11—adipose tissue—type 2 diabetes mellitus	0.000179	0.00272	CbGeAlD
Metformin—NDUFB8—pancreas—type 2 diabetes mellitus	0.000178	0.00271	CbGeAlD
Metformin—NDUFS5—pancreas—type 2 diabetes mellitus	0.000178	0.00271	CbGeAlD
Metformin—NDUFA8—cortex of kidney—type 2 diabetes mellitus	0.000178	0.00271	CbGeAlD
Metformin—NDUFB9—cortex of kidney—type 2 diabetes mellitus	0.000178	0.00271	CbGeAlD
Metformin—NDUFAF4—adipose tissue—type 2 diabetes mellitus	0.000177	0.0027	CbGeAlD
Metformin—NDUFB6—adipose tissue—type 2 diabetes mellitus	0.000177	0.0027	CbGeAlD
Metformin—NDUFA4—cortex of kidney—type 2 diabetes mellitus	0.000177	0.00269	CbGeAlD
Metformin—NDUFS1—adipose tissue—type 2 diabetes mellitus	0.000176	0.00268	CbGeAlD
Metformin—NDUFV1—cortex of kidney—type 2 diabetes mellitus	0.000176	0.00267	CbGeAlD
Metformin—NDUFB11—cortex of kidney—type 2 diabetes mellitus	0.000176	0.00267	CbGeAlD
Metformin—NDUFC2—retina—type 2 diabetes mellitus	0.000175	0.00266	CbGeAlD
Metformin—PRKAB1—nephron tubule—type 2 diabetes mellitus	0.000175	0.00266	CbGeAlD
Metformin—NDUFB10—adipose tissue—type 2 diabetes mellitus	0.000175	0.00266	CbGeAlD
Metformin—NDUFB8—cortex of kidney—type 2 diabetes mellitus	0.000175	0.00266	CbGeAlD
Metformin—NDUFS5—cortex of kidney—type 2 diabetes mellitus	0.000175	0.00266	CbGeAlD
Metformin—NDUFA12—adipose tissue—type 2 diabetes mellitus	0.000174	0.00264	CbGeAlD
Metformin—NDUFB7—adipose tissue—type 2 diabetes mellitus	0.000174	0.00264	CbGeAlD
Metformin—NDUFB1—adipose tissue—type 2 diabetes mellitus	0.000172	0.00262	CbGeAlD
Metformin—NDUFS8—adipose tissue—type 2 diabetes mellitus	0.000172	0.00262	CbGeAlD
Metformin—NDUFS7—cardiovascular system—type 2 diabetes mellitus	0.000172	0.00261	CbGeAlD
Metformin—NDUFB5—adipose tissue—type 2 diabetes mellitus	0.00017	0.00259	CbGeAlD
Metformin—NDUFA6—adipose tissue—type 2 diabetes mellitus	0.00017	0.00259	CbGeAlD
Metformin—NDUFA13—liver—type 2 diabetes mellitus	0.000169	0.00257	CbGeAlD
Metformin—NDUFA9—liver—type 2 diabetes mellitus	0.000169	0.00257	CbGeAlD
Metformin—NDUFS4—adipose tissue—type 2 diabetes mellitus	0.000169	0.00257	CbGeAlD
Metformin—NDUFS2—retina—type 2 diabetes mellitus	0.000168	0.00256	CbGeAlD
Metformin—NDUFS7—kidney—type 2 diabetes mellitus	0.000168	0.00256	CbGeAlD
Metformin—NDUFB4—adipose tissue—type 2 diabetes mellitus	0.000167	0.00254	CbGeAlD
Metformin—NDUFA1—liver—type 2 diabetes mellitus	0.000167	0.00253	CbGeAlD
Metformin—NDUFAB1—adipose tissue—type 2 diabetes mellitus	0.000166	0.00252	CbGeAlD
Metformin—NDUFB9—adipose tissue—type 2 diabetes mellitus	0.000165	0.0025	CbGeAlD
Metformin—NDUFA8—adipose tissue—type 2 diabetes mellitus	0.000165	0.0025	CbGeAlD
Metformin—NDUFS7—cortex of kidney—type 2 diabetes mellitus	0.000164	0.00249	CbGeAlD
Metformin—NDUFA4—adipose tissue—type 2 diabetes mellitus	0.000164	0.00249	CbGeAlD
Metformin—NDUFV1—adipose tissue—type 2 diabetes mellitus	0.000163	0.00247	CbGeAlD
Metformin—NDUFB11—adipose tissue—type 2 diabetes mellitus	0.000163	0.00247	CbGeAlD
Metformin—NDUFV2—liver—type 2 diabetes mellitus	0.000162	0.00246	CbGeAlD
Metformin—NDUFS5—adipose tissue—type 2 diabetes mellitus	0.000162	0.00246	CbGeAlD
Metformin—NDUFB8—adipose tissue—type 2 diabetes mellitus	0.000162	0.00246	CbGeAlD
Metformin—NDUFS2—nephron tubule—type 2 diabetes mellitus	0.000159	0.00241	CbGeAlD
Metformin—NDUFS3—nephron tubule—type 2 diabetes mellitus	0.000157	0.00238	CbGeAlD
Metformin—PRKAB1—kidney—type 2 diabetes mellitus	0.000154	0.00234	CbGeAlD
Metformin—PRKAB1—pancreas—type 2 diabetes mellitus	0.000153	0.00232	CbGeAlD
Metformin—NDUFS7—adipose tissue—type 2 diabetes mellitus	0.000152	0.0023	CbGeAlD
Metformin—PRKAB1—cortex of kidney—type 2 diabetes mellitus	0.00015	0.00228	CbGeAlD
Metformin—NDUFC2—cardiovascular system—type 2 diabetes mellitus	0.000148	0.00225	CbGeAlD
Metformin—ND5—liver—type 2 diabetes mellitus	0.000148	0.00225	CbGeAlD
Metformin—ND3—liver—type 2 diabetes mellitus	0.000148	0.00225	CbGeAlD
Metformin—ND2—liver—type 2 diabetes mellitus	0.000148	0.00225	CbGeAlD
Metformin—ND4L—liver—type 2 diabetes mellitus	0.000148	0.00225	CbGeAlD
Metformin—NDUFC2—kidney—type 2 diabetes mellitus	0.000145	0.0022	CbGeAlD
Metformin—ND4—liver—type 2 diabetes mellitus	0.000143	0.00218	CbGeAlD
Metformin—NDUFS2—cardiovascular system—type 2 diabetes mellitus	0.000143	0.00217	CbGeAlD
Metformin—NDUFC2—cortex of kidney—type 2 diabetes mellitus	0.000141	0.00215	CbGeAlD
Metformin—NDUFS3—cardiovascular system—type 2 diabetes mellitus	0.000141	0.00214	CbGeAlD
Metformin—NDUFA2—liver—type 2 diabetes mellitus	0.00014	0.00213	CbGeAlD
Metformin—NDUFS2—kidney—type 2 diabetes mellitus	0.000139	0.00212	CbGeAlD
Metformin—PRKAB1—adipose tissue—type 2 diabetes mellitus	0.000139	0.00211	CbGeAlD
Metformin—NDUFS2—pancreas—type 2 diabetes mellitus	0.000139	0.0021	CbGeAlD
Metformin—NDUFS3—kidney—type 2 diabetes mellitus	0.000138	0.00209	CbGeAlD
Metformin—NDUFS3—pancreas—type 2 diabetes mellitus	0.000137	0.00208	CbGeAlD
Metformin—NDUFS2—cortex of kidney—type 2 diabetes mellitus	0.000136	0.00206	CbGeAlD
Metformin—NDUFS3—cortex of kidney—type 2 diabetes mellitus	0.000134	0.00204	CbGeAlD
Metformin—NDUFA10—liver—type 2 diabetes mellitus	0.000134	0.00203	CbGeAlD
Metformin—NDUFC1—liver—type 2 diabetes mellitus	0.000133	0.00202	CbGeAlD
Metformin—NDUFB2—liver—type 2 diabetes mellitus	0.000132	0.002	CbGeAlD
Metformin—NDUFC2—adipose tissue—type 2 diabetes mellitus	0.000131	0.00199	CbGeAlD
Metformin—NDUFAF1—liver—type 2 diabetes mellitus	0.00013	0.00198	CbGeAlD
Metformin—ND6—liver—type 2 diabetes mellitus	0.000129	0.00197	CbGeAlD
Metformin—NDUFB3—liver—type 2 diabetes mellitus	0.000128	0.00195	CbGeAlD
Metformin—NDUFAF2—liver—type 2 diabetes mellitus	0.000128	0.00195	CbGeAlD
Metformin—NDUFS2—adipose tissue—type 2 diabetes mellitus	0.000126	0.00191	CbGeAlD
Metformin—NDUFA5—liver—type 2 diabetes mellitus	0.000125	0.00191	CbGeAlD
Metformin—NDUFA11—liver—type 2 diabetes mellitus	0.000125	0.00191	CbGeAlD
Metformin—NDUFAF4—liver—type 2 diabetes mellitus	0.000124	0.00189	CbGeAlD
Metformin—NDUFB6—liver—type 2 diabetes mellitus	0.000124	0.00189	CbGeAlD
Metformin—NDUFS3—adipose tissue—type 2 diabetes mellitus	0.000124	0.00189	CbGeAlD
Metformin—NDUFS1—liver—type 2 diabetes mellitus	0.000124	0.00188	CbGeAlD
Metformin—NDUFB10—liver—type 2 diabetes mellitus	0.000123	0.00186	CbGeAlD
Metformin—NDUFB7—liver—type 2 diabetes mellitus	0.000122	0.00185	CbGeAlD
Metformin—NDUFA12—liver—type 2 diabetes mellitus	0.000122	0.00185	CbGeAlD
Metformin—NDUFB1—liver—type 2 diabetes mellitus	0.000121	0.00184	CbGeAlD
Metformin—NDUFS8—liver—type 2 diabetes mellitus	0.000121	0.00184	CbGeAlD
Metformin—NDUFB5—liver—type 2 diabetes mellitus	0.000119	0.00181	CbGeAlD
Metformin—NDUFA6—liver—type 2 diabetes mellitus	0.000119	0.00181	CbGeAlD
Metformin—NDUFS4—liver—type 2 diabetes mellitus	0.000119	0.0018	CbGeAlD
Metformin—NDUFB4—liver—type 2 diabetes mellitus	0.000117	0.00178	CbGeAlD
Metformin—ND1—cardiovascular system—type 2 diabetes mellitus	0.000117	0.00178	CbGeAlD
Metformin—NDUFAB1—liver—type 2 diabetes mellitus	0.000116	0.00177	CbGeAlD
Metformin—NDUFB9—liver—type 2 diabetes mellitus	0.000116	0.00176	CbGeAlD
Metformin—NDUFA8—liver—type 2 diabetes mellitus	0.000116	0.00176	CbGeAlD
Metformin—NDUFA4—liver—type 2 diabetes mellitus	0.000115	0.00175	CbGeAlD
Metformin—ND1—kidney—type 2 diabetes mellitus	0.000114	0.00174	CbGeAlD
Metformin—NDUFV1—liver—type 2 diabetes mellitus	0.000114	0.00173	CbGeAlD
Metformin—NDUFB11—liver—type 2 diabetes mellitus	0.000114	0.00173	CbGeAlD
Metformin—ND1—pancreas—type 2 diabetes mellitus	0.000114	0.00173	CbGeAlD
Metformin—NDUFS5—liver—type 2 diabetes mellitus	0.000114	0.00172	CbGeAlD
Metformin—NDUFB8—liver—type 2 diabetes mellitus	0.000114	0.00172	CbGeAlD
Metformin—NDUFS7—liver—type 2 diabetes mellitus	0.000106	0.00162	CbGeAlD
Metformin—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000104	0.00159	CbGeAlD
Metformin—PRKAB1—liver—type 2 diabetes mellitus	9.73e-05	0.00148	CbGeAlD
Metformin—SLC22A2—kidney—type 2 diabetes mellitus	9.18e-05	0.00139	CbGeAlD
Metformin—NDUFC2—liver—type 2 diabetes mellitus	9.17e-05	0.00139	CbGeAlD
Metformin—SLC22A2—cortex of kidney—type 2 diabetes mellitus	8.94e-05	0.00136	CbGeAlD
Metformin—SLC47A1—nephron tubule—type 2 diabetes mellitus	8.84e-05	0.00134	CbGeAlD
Metformin—NDUFS2—liver—type 2 diabetes mellitus	8.81e-05	0.00134	CbGeAlD
Metformin—NDUFS3—liver—type 2 diabetes mellitus	8.71e-05	0.00132	CbGeAlD
Metformin—SLC47A1—kidney—type 2 diabetes mellitus	7.77e-05	0.00118	CbGeAlD
Metformin—SLC47A1—cortex of kidney—type 2 diabetes mellitus	7.57e-05	0.00115	CbGeAlD
Metformin—ND1—liver—type 2 diabetes mellitus	7.23e-05	0.0011	CbGeAlD
Metformin—SLC47A1—adipose tissue—type 2 diabetes mellitus	7e-05	0.00106	CbGeAlD
Metformin—SLC22A1—kidney—type 2 diabetes mellitus	6.48e-05	0.000985	CbGeAlD
Metformin—SLC22A3—kidney—type 2 diabetes mellitus	6.2e-05	0.000941	CbGeAlD
Metformin—SLC22A1—adipose tissue—type 2 diabetes mellitus	5.84e-05	0.000888	CbGeAlD
Metformin—SLC22A3—adipose tissue—type 2 diabetes mellitus	5.59e-05	0.000849	CbGeAlD
Metformin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	5.37e-05	0.000596	CcSEcCtD
Metformin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	5.35e-05	0.000594	CcSEcCtD
Metformin—Vomiting—Glipizide—type 2 diabetes mellitus	5.34e-05	0.000593	CcSEcCtD
Metformin—Oedema—Valsartan—type 2 diabetes mellitus	5.34e-05	0.000593	CcSEcCtD
Metformin—Feeling abnormal—Glyburide—type 2 diabetes mellitus	5.33e-05	0.000592	CcSEcCtD
Metformin—Dizziness—Pioglitazone—type 2 diabetes mellitus	5.32e-05	0.000591	CcSEcCtD
Metformin—Infection—Valsartan—type 2 diabetes mellitus	5.3e-05	0.000589	CcSEcCtD
Metformin—Rash—Glipizide—type 2 diabetes mellitus	5.3e-05	0.000589	CcSEcCtD
Metformin—Vision blurred—Irbesartan—type 2 diabetes mellitus	5.29e-05	0.000588	CcSEcCtD
Metformin—Dermatitis—Glipizide—type 2 diabetes mellitus	5.29e-05	0.000588	CcSEcCtD
Metformin—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	5.29e-05	0.000588	CcSEcCtD
Metformin—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	5.29e-05	0.000587	CcSEcCtD
Metformin—Erythema—Losartan—type 2 diabetes mellitus	5.29e-05	0.000587	CcSEcCtD
Metformin—Oedema—Orlistat—type 2 diabetes mellitus	5.27e-05	0.000586	CcSEcCtD
Metformin—Headache—Glipizide—type 2 diabetes mellitus	5.26e-05	0.000585	CcSEcCtD
Metformin—Tremor—Irbesartan—type 2 diabetes mellitus	5.26e-05	0.000585	CcSEcCtD
Metformin—Shock—Valsartan—type 2 diabetes mellitus	5.25e-05	0.000583	CcSEcCtD
Metformin—Infection—Orlistat—type 2 diabetes mellitus	5.24e-05	0.000582	CcSEcCtD
Metformin—Nervous system disorder—Valsartan—type 2 diabetes mellitus	5.23e-05	0.000581	CcSEcCtD
Metformin—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	5.22e-05	0.00058	CcSEcCtD
Metformin—Paraesthesia—Gliclazide—type 2 diabetes mellitus	5.21e-05	0.000579	CcSEcCtD
Metformin—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	5.21e-05	0.000579	CcSEcCtD
Metformin—Flatulence—Losartan—type 2 diabetes mellitus	5.21e-05	0.000579	CcSEcCtD
Metformin—Hepatitis—Ramipril—type 2 diabetes mellitus	5.21e-05	0.000578	CcSEcCtD
Metformin—Dizziness—Glimepiride—type 2 diabetes mellitus	5.19e-05	0.000576	CcSEcCtD
Metformin—Skin disorder—Valsartan—type 2 diabetes mellitus	5.18e-05	0.000576	CcSEcCtD
Metformin—Dysgeusia—Losartan—type 2 diabetes mellitus	5.18e-05	0.000575	CcSEcCtD
Metformin—Dyspnoea—Gliclazide—type 2 diabetes mellitus	5.18e-05	0.000575	CcSEcCtD
Metformin—Nervous system disorder—Orlistat—type 2 diabetes mellitus	5.17e-05	0.000574	CcSEcCtD
Metformin—Dizziness—Sitagliptin—type 2 diabetes mellitus	5.17e-05	0.000574	CcSEcCtD
Metformin—Somnolence—Gliclazide—type 2 diabetes mellitus	5.16e-05	0.000573	CcSEcCtD
Metformin—Urticaria—Glyburide—type 2 diabetes mellitus	5.14e-05	0.000571	CcSEcCtD
Metformin—Oedema peripheral—Ramipril—type 2 diabetes mellitus	5.13e-05	0.00057	CcSEcCtD
Metformin—Skin disorder—Orlistat—type 2 diabetes mellitus	5.12e-05	0.000569	CcSEcCtD
Metformin—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	5.12e-05	0.000568	CcSEcCtD
Metformin—Abdominal pain—Glyburide—type 2 diabetes mellitus	5.11e-05	0.000568	CcSEcCtD
Metformin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	5.11e-05	0.000568	CcSEcCtD
Metformin—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	5.1e-05	0.000566	CcSEcCtD
Metformin—Anorexia—Valsartan—type 2 diabetes mellitus	5.09e-05	0.000565	CcSEcCtD
Metformin—Muscle spasms—Losartan—type 2 diabetes mellitus	5.08e-05	0.000565	CcSEcCtD
Metformin—Asthenia—Bromocriptine—type 2 diabetes mellitus	5.08e-05	0.000564	CcSEcCtD
Metformin—Malaise—Irbesartan—type 2 diabetes mellitus	5.07e-05	0.000563	CcSEcCtD
Metformin—Headache—Pioglitazone—type 2 diabetes mellitus	5.04e-05	0.00056	CcSEcCtD
Metformin—Syncope—Irbesartan—type 2 diabetes mellitus	5.04e-05	0.00056	CcSEcCtD
Metformin—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	5.01e-05	0.000557	CcSEcCtD
Metformin—Fatigue—Gliclazide—type 2 diabetes mellitus	5.01e-05	0.000556	CcSEcCtD
Metformin—Nausea—Glipizide—type 2 diabetes mellitus	4.99e-05	0.000554	CcSEcCtD
Metformin—Vomiting—Glimepiride—type 2 diabetes mellitus	4.99e-05	0.000554	CcSEcCtD
Metformin—Hypotension—Valsartan—type 2 diabetes mellitus	4.99e-05	0.000554	CcSEcCtD
Metformin—Vision blurred—Losartan—type 2 diabetes mellitus	4.98e-05	0.000553	CcSEcCtD
Metformin—Vomiting—Sitagliptin—type 2 diabetes mellitus	4.97e-05	0.000552	CcSEcCtD
Metformin—Constipation—Gliclazide—type 2 diabetes mellitus	4.97e-05	0.000552	CcSEcCtD
Metformin—Tremor—Losartan—type 2 diabetes mellitus	4.95e-05	0.00055	CcSEcCtD
Metformin—Rash—Glimepiride—type 2 diabetes mellitus	4.94e-05	0.000549	CcSEcCtD
Metformin—Dermatitis—Glimepiride—type 2 diabetes mellitus	4.94e-05	0.000549	CcSEcCtD
Metformin—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	4.94e-05	0.000548	CcSEcCtD
Metformin—Rash—Sitagliptin—type 2 diabetes mellitus	4.93e-05	0.000547	CcSEcCtD
Metformin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	4.92e-05	0.000547	CcSEcCtD
Metformin—Headache—Glimepiride—type 2 diabetes mellitus	4.91e-05	0.000546	CcSEcCtD
Metformin—SLC47A1—liver—type 2 diabetes mellitus	4.91e-05	0.000746	CbGeAlD
Metformin—Ill-defined disorder—Losartan—type 2 diabetes mellitus	4.91e-05	0.000545	CcSEcCtD
Metformin—Headache—Sitagliptin—type 2 diabetes mellitus	4.9e-05	0.000544	CcSEcCtD
Metformin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	4.86e-05	0.00054	CcSEcCtD
Metformin—Hypertension—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.000539	CcSEcCtD
Metformin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	4.84e-05	0.000538	CcSEcCtD
Metformin—Flushing—Ramipril—type 2 diabetes mellitus	4.83e-05	0.000537	CcSEcCtD
Metformin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	4.8e-05	0.000534	CcSEcCtD
Metformin—Paraesthesia—Valsartan—type 2 diabetes mellitus	4.79e-05	0.000532	CcSEcCtD
Metformin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	4.79e-05	0.000532	CcSEcCtD
Metformin—Chest pain—Irbesartan—type 2 diabetes mellitus	4.78e-05	0.000531	CcSEcCtD
Metformin—Myalgia—Irbesartan—type 2 diabetes mellitus	4.78e-05	0.000531	CcSEcCtD
Metformin—Malaise—Losartan—type 2 diabetes mellitus	4.77e-05	0.00053	CcSEcCtD
Metformin—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.76e-05	0.000528	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	4.75e-05	0.000528	CcSEcCtD
Metformin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.75e-05	0.000527	CcSEcCtD
Metformin—Somnolence—Valsartan—type 2 diabetes mellitus	4.74e-05	0.000527	CcSEcCtD
Metformin—Syncope—Losartan—type 2 diabetes mellitus	4.74e-05	0.000527	CcSEcCtD
Metformin—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.73e-05	0.000526	CcSEcCtD
Metformin—Discomfort—Irbesartan—type 2 diabetes mellitus	4.73e-05	0.000525	CcSEcCtD
Metformin—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000522	CcSEcCtD
Metformin—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.7e-05	0.000522	CcSEcCtD
Metformin—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	4.69e-05	0.000521	CcSEcCtD
Metformin—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.68e-05	0.00052	CcSEcCtD
Metformin—Palpitations—Losartan—type 2 diabetes mellitus	4.67e-05	0.000519	CcSEcCtD
Metformin—Nausea—Glimepiride—type 2 diabetes mellitus	4.66e-05	0.000517	CcSEcCtD
Metformin—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.65e-05	0.000516	CcSEcCtD
Metformin—Nausea—Sitagliptin—type 2 diabetes mellitus	4.64e-05	0.000516	CcSEcCtD
Metformin—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.64e-05	0.000515	CcSEcCtD
Metformin—Asthenia—Glyburide—type 2 diabetes mellitus	4.64e-05	0.000515	CcSEcCtD
Metformin—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.64e-05	0.000515	CcSEcCtD
Metformin—Urticaria—Gliclazide—type 2 diabetes mellitus	4.61e-05	0.000512	CcSEcCtD
Metformin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.61e-05	0.000512	CcSEcCtD
Metformin—Fatigue—Valsartan—type 2 diabetes mellitus	4.6e-05	0.000511	CcSEcCtD
Metformin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.59e-05	0.00051	CcSEcCtD
Metformin—Oedema—Irbesartan—type 2 diabetes mellitus	4.59e-05	0.000509	CcSEcCtD
Metformin—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.58e-05	0.000509	CcSEcCtD
Metformin—Pruritus—Glyburide—type 2 diabetes mellitus	4.58e-05	0.000508	CcSEcCtD
Metformin—Constipation—Valsartan—type 2 diabetes mellitus	4.56e-05	0.000507	CcSEcCtD
Metformin—Infection—Irbesartan—type 2 diabetes mellitus	4.56e-05	0.000506	CcSEcCtD
Metformin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.55e-05	0.000506	CcSEcCtD
Metformin—Fatigue—Orlistat—type 2 diabetes mellitus	4.55e-05	0.000505	CcSEcCtD
Metformin—Erythema—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000504	CcSEcCtD
Metformin—Malnutrition—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000504	CcSEcCtD
Metformin—Shock—Irbesartan—type 2 diabetes mellitus	4.51e-05	0.000501	CcSEcCtD
Metformin—Chest pain—Losartan—type 2 diabetes mellitus	4.5e-05	0.0005	CcSEcCtD
Metformin—Myalgia—Losartan—type 2 diabetes mellitus	4.5e-05	0.0005	CcSEcCtD
Metformin—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.5e-05	0.0005	CcSEcCtD
Metformin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.5e-05	0.000499	CcSEcCtD
Metformin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.49e-05	0.000499	CcSEcCtD
Metformin—Rash—Bromocriptine—type 2 diabetes mellitus	4.46e-05	0.000495	CcSEcCtD
Metformin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.46e-05	0.000495	CcSEcCtD
Metformin—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.45e-05	0.000495	CcSEcCtD
Metformin—Discomfort—Losartan—type 2 diabetes mellitus	4.45e-05	0.000494	CcSEcCtD
Metformin—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.44e-05	0.000493	CcSEcCtD
Metformin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.43e-05	0.000492	CcSEcCtD
Metformin—Headache—Bromocriptine—type 2 diabetes mellitus	4.43e-05	0.000492	CcSEcCtD
Metformin—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.43e-05	0.000492	CcSEcCtD
Metformin—Anorexia—Irbesartan—type 2 diabetes mellitus	4.37e-05	0.000485	CcSEcCtD
Metformin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.36e-05	0.000485	CcSEcCtD
Metformin—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000484	CcSEcCtD
Metformin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.34e-05	0.000483	CcSEcCtD
Metformin—Oedema—Losartan—type 2 diabetes mellitus	4.32e-05	0.000479	CcSEcCtD
Metformin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.31e-05	0.000479	CcSEcCtD
Metformin—Infection—Losartan—type 2 diabetes mellitus	4.29e-05	0.000476	CcSEcCtD
Metformin—Hypotension—Irbesartan—type 2 diabetes mellitus	4.28e-05	0.000476	CcSEcCtD
Metformin—Tremor—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000472	CcSEcCtD
Metformin—Shock—Losartan—type 2 diabetes mellitus	4.25e-05	0.000472	CcSEcCtD
Metformin—Urticaria—Valsartan—type 2 diabetes mellitus	4.24e-05	0.000471	CcSEcCtD
Metformin—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.23e-05	0.00047	CcSEcCtD
Metformin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.23e-05	0.000469	CcSEcCtD
Metformin—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.22e-05	0.000468	CcSEcCtD
Metformin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.21e-05	0.000467	CcSEcCtD
Metformin—Nausea—Bromocriptine—type 2 diabetes mellitus	4.2e-05	0.000467	CcSEcCtD
Metformin—Urticaria—Orlistat—type 2 diabetes mellitus	4.19e-05	0.000465	CcSEcCtD
Metformin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.18e-05	0.000464	CcSEcCtD
Metformin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.17e-05	0.000463	CcSEcCtD
Metformin—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.17e-05	0.000463	CcSEcCtD
Metformin—Asthenia—Gliclazide—type 2 diabetes mellitus	4.17e-05	0.000463	CcSEcCtD
Metformin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.12e-05	0.000457	CcSEcCtD
Metformin—Anorexia—Losartan—type 2 diabetes mellitus	4.11e-05	0.000457	CcSEcCtD
Metformin—Vomiting—Glyburide—type 2 diabetes mellitus	4.11e-05	0.000457	CcSEcCtD
Metformin—Pruritus—Gliclazide—type 2 diabetes mellitus	4.11e-05	0.000456	CcSEcCtD
Metformin—SLC22A1—liver—type 2 diabetes mellitus	4.1e-05	0.000623	CbGeAlD
Metformin—Malaise—Ramipril—type 2 diabetes mellitus	4.09e-05	0.000454	CcSEcCtD
Metformin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.09e-05	0.000454	CcSEcCtD
Metformin—Rash—Glyburide—type 2 diabetes mellitus	4.08e-05	0.000453	CcSEcCtD
Metformin—Somnolence—Irbesartan—type 2 diabetes mellitus	4.08e-05	0.000453	CcSEcCtD
Metformin—Dermatitis—Glyburide—type 2 diabetes mellitus	4.07e-05	0.000453	CcSEcCtD
Metformin—Syncope—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000452	CcSEcCtD
Metformin—Headache—Glyburide—type 2 diabetes mellitus	4.05e-05	0.00045	CcSEcCtD
Metformin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.04e-05	0.000448	CcSEcCtD
Metformin—Hypotension—Losartan—type 2 diabetes mellitus	4.03e-05	0.000448	CcSEcCtD
Metformin—Palpitations—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000445	CcSEcCtD
Metformin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.99e-05	0.000443	CcSEcCtD
Metformin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000443	CcSEcCtD
Metformin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.97e-05	0.000441	CcSEcCtD
Metformin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.96e-05	0.00044	CcSEcCtD
Metformin—Fatigue—Irbesartan—type 2 diabetes mellitus	3.95e-05	0.000439	CcSEcCtD
Metformin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.93e-05	0.000437	CcSEcCtD
Metformin—Constipation—Irbesartan—type 2 diabetes mellitus	3.92e-05	0.000436	CcSEcCtD
Metformin—SLC22A3—liver—type 2 diabetes mellitus	3.92e-05	0.000595	CbGeAlD
Metformin—Paraesthesia—Losartan—type 2 diabetes mellitus	3.87e-05	0.00043	CcSEcCtD
Metformin—Myalgia—Ramipril—type 2 diabetes mellitus	3.86e-05	0.000429	CcSEcCtD
Metformin—Chest pain—Ramipril—type 2 diabetes mellitus	3.86e-05	0.000429	CcSEcCtD
Metformin—Dyspnoea—Losartan—type 2 diabetes mellitus	3.85e-05	0.000427	CcSEcCtD
Metformin—Nausea—Glyburide—type 2 diabetes mellitus	3.84e-05	0.000427	CcSEcCtD
Metformin—Dizziness—Gliclazide—type 2 diabetes mellitus	3.84e-05	0.000427	CcSEcCtD
Metformin—Somnolence—Losartan—type 2 diabetes mellitus	3.84e-05	0.000426	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.83e-05	0.000426	CcSEcCtD
Metformin—Asthenia—Valsartan—type 2 diabetes mellitus	3.83e-05	0.000425	CcSEcCtD
Metformin—Discomfort—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000424	CcSEcCtD
Metformin—Dyspepsia—Losartan—type 2 diabetes mellitus	3.8e-05	0.000422	CcSEcCtD
Metformin—Asthenia—Orlistat—type 2 diabetes mellitus	3.78e-05	0.00042	CcSEcCtD
Metformin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.78e-05	0.00042	CcSEcCtD
Metformin—Pruritus—Valsartan—type 2 diabetes mellitus	3.77e-05	0.000419	CcSEcCtD
Metformin—Decreased appetite—Losartan—type 2 diabetes mellitus	3.75e-05	0.000417	CcSEcCtD
Metformin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.75e-05	0.000416	CcSEcCtD
Metformin—Pruritus—Orlistat—type 2 diabetes mellitus	3.73e-05	0.000414	CcSEcCtD
Metformin—Fatigue—Losartan—type 2 diabetes mellitus	3.72e-05	0.000413	CcSEcCtD
Metformin—Oedema—Ramipril—type 2 diabetes mellitus	3.7e-05	0.000411	CcSEcCtD
Metformin—Vomiting—Gliclazide—type 2 diabetes mellitus	3.69e-05	0.00041	CcSEcCtD
Metformin—Constipation—Losartan—type 2 diabetes mellitus	3.69e-05	0.00041	CcSEcCtD
Metformin—Rash—Gliclazide—type 2 diabetes mellitus	3.66e-05	0.000407	CcSEcCtD
Metformin—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.66e-05	0.000406	CcSEcCtD
Metformin—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.65e-05	0.000405	CcSEcCtD
Metformin—Urticaria—Irbesartan—type 2 diabetes mellitus	3.64e-05	0.000405	CcSEcCtD
Metformin—Shock—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000404	CcSEcCtD
Metformin—Headache—Gliclazide—type 2 diabetes mellitus	3.64e-05	0.000404	CcSEcCtD
Metformin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000403	CcSEcCtD
Metformin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.62e-05	0.000403	CcSEcCtD
Metformin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.62e-05	0.000402	CcSEcCtD
Metformin—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.61e-05	0.000401	CcSEcCtD
Metformin—Skin disorder—Ramipril—type 2 diabetes mellitus	3.59e-05	0.000399	CcSEcCtD
Metformin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.58e-05	0.000397	CcSEcCtD
Metformin—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.56e-05	0.000395	CcSEcCtD
Metformin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.53e-05	0.000392	CcSEcCtD
Metformin—Dizziness—Valsartan—type 2 diabetes mellitus	3.53e-05	0.000392	CcSEcCtD
Metformin—Anorexia—Ramipril—type 2 diabetes mellitus	3.53e-05	0.000392	CcSEcCtD
Metformin—Dizziness—Orlistat—type 2 diabetes mellitus	3.49e-05	0.000387	CcSEcCtD
Metformin—Hypotension—Ramipril—type 2 diabetes mellitus	3.46e-05	0.000384	CcSEcCtD
Metformin—Nausea—Gliclazide—type 2 diabetes mellitus	3.45e-05	0.000383	CcSEcCtD
Metformin—Urticaria—Losartan—type 2 diabetes mellitus	3.43e-05	0.000381	CcSEcCtD
Metformin—Abdominal pain—Losartan—type 2 diabetes mellitus	3.41e-05	0.000379	CcSEcCtD
Metformin—Vomiting—Valsartan—type 2 diabetes mellitus	3.39e-05	0.000377	CcSEcCtD
Metformin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.37e-05	0.000374	CcSEcCtD
Metformin—Rash—Valsartan—type 2 diabetes mellitus	3.36e-05	0.000374	CcSEcCtD
Metformin—Dermatitis—Valsartan—type 2 diabetes mellitus	3.36e-05	0.000373	CcSEcCtD
Metformin—Vomiting—Orlistat—type 2 diabetes mellitus	3.35e-05	0.000372	CcSEcCtD
Metformin—Headache—Valsartan—type 2 diabetes mellitus	3.34e-05	0.000371	CcSEcCtD
Metformin—Rash—Orlistat—type 2 diabetes mellitus	3.32e-05	0.000369	CcSEcCtD
Metformin—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.32e-05	0.000369	CcSEcCtD
Metformin—Dermatitis—Orlistat—type 2 diabetes mellitus	3.32e-05	0.000369	CcSEcCtD
Metformin—Headache—Orlistat—type 2 diabetes mellitus	3.3e-05	0.000367	CcSEcCtD
Metformin—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000366	CcSEcCtD
Metformin—Asthenia—Irbesartan—type 2 diabetes mellitus	3.29e-05	0.000365	CcSEcCtD
Metformin—Somnolence—Ramipril—type 2 diabetes mellitus	3.29e-05	0.000365	CcSEcCtD
Metformin—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.26e-05	0.000362	CcSEcCtD
Metformin—Pruritus—Irbesartan—type 2 diabetes mellitus	3.24e-05	0.00036	CcSEcCtD
Metformin—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.22e-05	0.000357	CcSEcCtD
Metformin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.19e-05	0.000355	CcSEcCtD
Metformin—Fatigue—Ramipril—type 2 diabetes mellitus	3.19e-05	0.000354	CcSEcCtD
Metformin—Nausea—Valsartan—type 2 diabetes mellitus	3.17e-05	0.000352	CcSEcCtD
Metformin—Constipation—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000351	CcSEcCtD
Metformin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.14e-05	0.000348	CcSEcCtD
Metformin—Nausea—Orlistat—type 2 diabetes mellitus	3.13e-05	0.000348	CcSEcCtD
Metformin—Asthenia—Losartan—type 2 diabetes mellitus	3.1e-05	0.000344	CcSEcCtD
Metformin—Pruritus—Losartan—type 2 diabetes mellitus	3.05e-05	0.000339	CcSEcCtD
Metformin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000339	CcSEcCtD
Metformin—Dizziness—Irbesartan—type 2 diabetes mellitus	3.03e-05	0.000337	CcSEcCtD
Metformin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000336	CcSEcCtD
Metformin—Diarrhoea—Losartan—type 2 diabetes mellitus	2.95e-05	0.000328	CcSEcCtD
Metformin—Urticaria—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000326	CcSEcCtD
Metformin—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.93e-05	0.000325	CcSEcCtD
Metformin—Vomiting—Irbesartan—type 2 diabetes mellitus	2.92e-05	0.000324	CcSEcCtD
Metformin—Rash—Irbesartan—type 2 diabetes mellitus	2.89e-05	0.000321	CcSEcCtD
Metformin—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.89e-05	0.000321	CcSEcCtD
Metformin—Headache—Irbesartan—type 2 diabetes mellitus	2.87e-05	0.000319	CcSEcCtD
Metformin—Dizziness—Losartan—type 2 diabetes mellitus	2.85e-05	0.000317	CcSEcCtD
Metformin—Vomiting—Losartan—type 2 diabetes mellitus	2.74e-05	0.000305	CcSEcCtD
Metformin—Nausea—Irbesartan—type 2 diabetes mellitus	2.72e-05	0.000303	CcSEcCtD
Metformin—Rash—Losartan—type 2 diabetes mellitus	2.72e-05	0.000302	CcSEcCtD
Metformin—Dermatitis—Losartan—type 2 diabetes mellitus	2.72e-05	0.000302	CcSEcCtD
Metformin—Headache—Losartan—type 2 diabetes mellitus	2.7e-05	0.0003	CcSEcCtD
Metformin—Asthenia—Ramipril—type 2 diabetes mellitus	2.65e-05	0.000295	CcSEcCtD
Metformin—Pruritus—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000291	CcSEcCtD
Metformin—Nausea—Losartan—type 2 diabetes mellitus	2.56e-05	0.000285	CcSEcCtD
Metformin—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.53e-05	0.000281	CcSEcCtD
Metformin—Dizziness—Ramipril—type 2 diabetes mellitus	2.45e-05	0.000272	CcSEcCtD
Metformin—Vomiting—Ramipril—type 2 diabetes mellitus	2.35e-05	0.000261	CcSEcCtD
Metformin—Rash—Ramipril—type 2 diabetes mellitus	2.33e-05	0.000259	CcSEcCtD
Metformin—Dermatitis—Ramipril—type 2 diabetes mellitus	2.33e-05	0.000259	CcSEcCtD
Metformin—Headache—Ramipril—type 2 diabetes mellitus	2.32e-05	0.000257	CcSEcCtD
Metformin—Nausea—Ramipril—type 2 diabetes mellitus	2.2e-05	0.000244	CcSEcCtD
Metformin—ND1—Metabolism—INS—type 2 diabetes mellitus	1.31e-06	1.23e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.3e-06	1.23e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCC8—type 2 diabetes mellitus	1.3e-06	1.23e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CBS—type 2 diabetes mellitus	1.3e-06	1.23e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—UCP3—type 2 diabetes mellitus	1.3e-06	1.22e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.3e-06	1.22e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—UCP2—type 2 diabetes mellitus	1.3e-06	1.22e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—AKT1—type 2 diabetes mellitus	1.27e-06	1.2e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—C3—type 2 diabetes mellitus	1.27e-06	1.2e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.25e-06	1.18e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SREBF1—type 2 diabetes mellitus	1.25e-06	1.18e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SNAP25—type 2 diabetes mellitus	1.25e-06	1.18e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PSMD6—type 2 diabetes mellitus	1.25e-06	1.18e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.25e-06	1.18e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—COX2—type 2 diabetes mellitus	1.25e-06	1.18e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.25e-06	1.18e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.24e-06	1.17e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CTGF—type 2 diabetes mellitus	1.23e-06	1.16e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NCOA6—type 2 diabetes mellitus	1.23e-06	1.16e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PCK1—type 2 diabetes mellitus	1.22e-06	1.15e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—HMGCR—type 2 diabetes mellitus	1.22e-06	1.15e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.21e-06	1.14e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.21e-06	1.14e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.21e-06	1.14e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—UCP2—type 2 diabetes mellitus	1.21e-06	1.14e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—UCP3—type 2 diabetes mellitus	1.21e-06	1.14e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.21e-06	1.14e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—ALB—type 2 diabetes mellitus	1.2e-06	1.13e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.2e-06	1.13e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.2e-06	1.13e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ADRA2A—type 2 diabetes mellitus	1.19e-06	1.12e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.19e-06	1.12e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.18e-06	1.12e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.18e-06	1.12e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.17e-06	1.1e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.17e-06	1.1e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	1.1e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	1.1e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	1.1e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	1.1e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.16e-06	1.1e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.15e-06	1.09e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.15e-06	1.08e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—NOS3—type 2 diabetes mellitus	1.15e-06	1.08e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP2E1—type 2 diabetes mellitus	1.15e-06	1.08e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HK1—type 2 diabetes mellitus	1.14e-06	1.08e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PCK1—type 2 diabetes mellitus	1.14e-06	1.07e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SLC2A1—type 2 diabetes mellitus	1.13e-06	1.07e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP1A2—type 2 diabetes mellitus	1.13e-06	1.07e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.12e-06	1.05e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.12e-06	1.05e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.11e-06	1.05e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP3A4—type 2 diabetes mellitus	1.11e-06	1.04e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GCKR—type 2 diabetes mellitus	1.1e-06	1.04e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HSD3B2—type 2 diabetes mellitus	1.1e-06	1.04e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—KCNJ11—type 2 diabetes mellitus	1.1e-06	1.04e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—LPA—type 2 diabetes mellitus	1.1e-06	1.04e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GCG—type 2 diabetes mellitus	1.09e-06	1.02e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SLC2A4—type 2 diabetes mellitus	1.09e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HK1—type 2 diabetes mellitus	1.06e-06	1e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALDOB—type 2 diabetes mellitus	1.06e-06	9.96e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.06e-06	9.95e-06	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—type 2 diabetes mellitus	1.05e-06	9.9e-06	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.04e-06	9.82e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—LPA—type 2 diabetes mellitus	1.03e-06	9.69e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.03e-06	9.69e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GCKR—type 2 diabetes mellitus	1.03e-06	9.69e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.03e-06	9.69e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—INS—type 2 diabetes mellitus	1.01e-06	9.53e-06	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.01e-06	9.5e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.95e-07	9.37e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALDOB—type 2 diabetes mellitus	9.86e-07	9.29e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GLP1R—type 2 diabetes mellitus	9.83e-07	9.26e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.78e-07	9.22e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.78e-07	9.21e-06	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AKT1—type 2 diabetes mellitus	9.64e-07	9.08e-06	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.46e-07	8.91e-06	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	9.4e-07	8.86e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GNB3—type 2 diabetes mellitus	9.37e-07	8.82e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.37e-07	8.82e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—HMOX1—type 2 diabetes mellitus	9.32e-07	8.78e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.29e-07	8.75e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CAT—type 2 diabetes mellitus	9.2e-07	8.67e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC2A2—type 2 diabetes mellitus	9.18e-07	8.65e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GLP1R—type 2 diabetes mellitus	9.17e-07	8.63e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CPT1A—type 2 diabetes mellitus	8.99e-07	8.47e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MTR—type 2 diabetes mellitus	8.99e-07	8.47e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—APOB—type 2 diabetes mellitus	8.93e-07	8.41e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.87e-07	8.36e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.87e-07	8.36e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NAMPT—type 2 diabetes mellitus	8.82e-07	8.31e-06	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.82e-07	8.31e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—LIPC—type 2 diabetes mellitus	8.77e-07	8.26e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GCK—type 2 diabetes mellitus	8.77e-07	8.26e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HBA1—type 2 diabetes mellitus	8.77e-07	8.26e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP11A1—type 2 diabetes mellitus	8.71e-07	8.21e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTM1—type 2 diabetes mellitus	8.69e-07	8.18e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC2A2—type 2 diabetes mellitus	8.56e-07	8.06e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC9A1—type 2 diabetes mellitus	8.56e-07	8.06e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—LPL—type 2 diabetes mellitus	8.53e-07	8.03e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CETP—type 2 diabetes mellitus	8.46e-07	7.97e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CPT1A—type 2 diabetes mellitus	8.38e-07	7.9e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MTR—type 2 diabetes mellitus	8.38e-07	7.9e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—RELA—type 2 diabetes mellitus	8.35e-07	7.87e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ADCY5—type 2 diabetes mellitus	8.35e-07	7.86e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GPX1—type 2 diabetes mellitus	8.32e-07	7.84e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NAMPT—type 2 diabetes mellitus	8.22e-07	7.74e-06	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AKT1—type 2 diabetes mellitus	8.2e-07	7.72e-06	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AKT1—type 2 diabetes mellitus	8.2e-07	7.72e-06	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AKT1—type 2 diabetes mellitus	8.2e-07	7.72e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HBA1—type 2 diabetes mellitus	8.17e-07	7.7e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—LIPC—type 2 diabetes mellitus	8.17e-07	7.7e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GCK—type 2 diabetes mellitus	8.17e-07	7.7e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP11A1—type 2 diabetes mellitus	8.12e-07	7.65e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CD36—type 2 diabetes mellitus	8.1e-07	7.63e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPP2CA—type 2 diabetes mellitus	8e-07	7.54e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC9A1—type 2 diabetes mellitus	7.97e-07	7.51e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CETP—type 2 diabetes mellitus	7.88e-07	7.42e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PSMD6—type 2 diabetes mellitus	7.86e-07	7.41e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SREBF1—type 2 diabetes mellitus	7.86e-07	7.41e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SNAP25—type 2 diabetes mellitus	7.86e-07	7.41e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CTGF—type 2 diabetes mellitus	7.72e-07	7.27e-06	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AKT1—type 2 diabetes mellitus	7.71e-07	7.26e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—MTHFR—type 2 diabetes mellitus	7.68e-07	7.23e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HMGCR—type 2 diabetes mellitus	7.65e-07	7.2e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPARA—type 2 diabetes mellitus	7.53e-07	7.1e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.53e-07	7.09e-06	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.5e-07	7.06e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ADRA2A—type 2 diabetes mellitus	7.48e-07	7.05e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PSMD6—type 2 diabetes mellitus	7.33e-07	6.9e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SNAP25—type 2 diabetes mellitus	7.33e-07	6.9e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SREBF1—type 2 diabetes mellitus	7.33e-07	6.9e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AGT—type 2 diabetes mellitus	7.3e-07	6.87e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CTGF—type 2 diabetes mellitus	7.19e-07	6.78e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP2E1—type 2 diabetes mellitus	7.19e-07	6.77e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CALM1—type 2 diabetes mellitus	7.17e-07	6.76e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—APOE—type 2 diabetes mellitus	7.15e-07	6.73e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HMGCR—type 2 diabetes mellitus	7.13e-07	6.71e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.12e-07	6.7e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC2A1—type 2 diabetes mellitus	7.11e-07	6.7e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP1A2—type 2 diabetes mellitus	7.11e-07	6.7e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—APOA1—type 2 diabetes mellitus	7.07e-07	6.66e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.04e-07	6.63e-06	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.99e-07	6.58e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ADRA2A—type 2 diabetes mellitus	6.98e-07	6.57e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP3A4—type 2 diabetes mellitus	6.93e-07	6.53e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GCG—type 2 diabetes mellitus	6.82e-07	6.42e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC2A4—type 2 diabetes mellitus	6.82e-07	6.42e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP2E1—type 2 diabetes mellitus	6.7e-07	6.31e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP1A2—type 2 diabetes mellitus	6.63e-07	6.24e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC2A1—type 2 diabetes mellitus	6.63e-07	6.24e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SRC—type 2 diabetes mellitus	6.56e-07	6.18e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP3A4—type 2 diabetes mellitus	6.46e-07	6.09e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.39e-07	6.02e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GCG—type 2 diabetes mellitus	6.35e-07	5.98e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC2A4—type 2 diabetes mellitus	6.35e-07	5.98e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPARG—type 2 diabetes mellitus	6.23e-07	5.87e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—INS—type 2 diabetes mellitus	6.11e-07	5.75e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.88e-07	5.53e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GNB3—type 2 diabetes mellitus	5.88e-07	5.53e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.87e-07	5.53e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HMOX1—type 2 diabetes mellitus	5.85e-07	5.51e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CAT—type 2 diabetes mellitus	5.77e-07	5.44e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.75e-07	5.42e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—APOB—type 2 diabetes mellitus	5.6e-07	5.28e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ALB—type 2 diabetes mellitus	5.6e-07	5.27e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GNB3—type 2 diabetes mellitus	5.48e-07	5.16e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.48e-07	5.16e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HMOX1—type 2 diabetes mellitus	5.45e-07	5.13e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTM1—type 2 diabetes mellitus	5.45e-07	5.13e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CAT—type 2 diabetes mellitus	5.38e-07	5.07e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NOS3—type 2 diabetes mellitus	5.36e-07	5.04e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3R1—type 2 diabetes mellitus	5.36e-07	5.04e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—LPL—type 2 diabetes mellitus	5.35e-07	5.04e-06	CbGpPWpGaD
Metformin—ND1—Metabolism—AKT1—type 2 diabetes mellitus	5.28e-07	4.98e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ADCY5—type 2 diabetes mellitus	5.24e-07	4.93e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—APOB—type 2 diabetes mellitus	5.22e-07	4.92e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GPX1—type 2 diabetes mellitus	5.22e-07	4.92e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CD36—type 2 diabetes mellitus	5.08e-07	4.79e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTM1—type 2 diabetes mellitus	5.08e-07	4.78e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPP2CA—type 2 diabetes mellitus	5.02e-07	4.73e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—LPL—type 2 diabetes mellitus	4.99e-07	4.7e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—type 2 diabetes mellitus	4.9e-07	4.61e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ADCY5—type 2 diabetes mellitus	4.88e-07	4.6e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GPX1—type 2 diabetes mellitus	4.86e-07	4.58e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MTHFR—type 2 diabetes mellitus	4.82e-07	4.54e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CD36—type 2 diabetes mellitus	4.74e-07	4.46e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPARA—type 2 diabetes mellitus	4.72e-07	4.45e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.68e-07	4.41e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	4.58e-07	4.31e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	4.5e-07	4.24e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MTHFR—type 2 diabetes mellitus	4.49e-07	4.23e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	4.48e-07	4.22e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	4.43e-07	4.17e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.42e-07	4.16e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPARA—type 2 diabetes mellitus	4.4e-07	4.15e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AGT—type 2 diabetes mellitus	4.27e-07	4.02e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	4.19e-07	3.95e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	4.18e-07	3.94e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	4.13e-07	3.89e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.08e-07	3.84e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	3.91e-07	3.68e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	3.83e-07	3.61e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	3.64e-07	3.43e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	3.57e-07	3.36e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	3.51e-07	3.31e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.36e-07	3.16e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	3.36e-07	3.16e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	3.27e-07	3.08e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.13e-07	2.95e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	3.13e-07	2.95e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	3.07e-07	2.89e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.86e-07	2.7e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKT1—type 2 diabetes mellitus	2.46e-07	2.32e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	1.54e-07	1.45e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	1.44e-07	1.36e-06	CbGpPWpGaD
